Skip to main content
Clinical Trials/KCT0004728
KCT0004728
Recruiting
未知

sefulness of acellular dermal matrix (Megaderm®) in breast cancer surgery

Myongji Hospital0 sites50 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Myongji Hospital
Enrollment
50
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Observational Study
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • (1\) Female patients aged \=19 years
  • (2\) Subjects to treat partial mastectomy or radical surgery of breast and axilla for diagnosis of breast cancer
  • (3\) Patients with breast cancer in stages 0\-3
  • (4\) Subjects who needed the using the Megaderm® before primary suture immediately after surgery.
  • (5\) Subject who can follow\-up investigation

Exclusion Criteria

  • (1\) 4th stage metastatic or inflammatory breast cancer patient
  • (2\) Patients with infectious diseases, autoimmune disease, and hemostatic disorder
  • (3\) Patients suspected of inflammatory infection in the breast before surgery
  • (4\) Pregnancy
  • (5\) Other, subjects deemed to be in difficulty with clinical research or not required to use Megaderm® by the judgment of the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials